tiprankstipranks
Trending News
More News >

Keurig upgraded, Global Payments downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.

Top 5 Upgrades:

  • HSBC upgraded Keurig Dr Pepper (KDP) to Buy from Hold with a price target of $42, up from $36. With Q1 net sales growth of 6% and comparable EPS up 10%, the company “managed to build some cushion for holding on to its full-year guidance,” says the firm, which sees the company being “in the right place with the right brands.”
  • KeyBanc upgraded Lowe’s (LOW) to Overweight from Sector Weight with a $266 price target. The firm sees a buying opportunity for “patient investors” into this “high-quality businesses” following the recent share pullback.
  • RBC Capital upgraded Procter & Gamble (PG) to Outperform from Sector Perform with a price target of $177, up from $164. The firm thinks investors should take advantage of Procter’s share pullback, “especially in this market.”
  • Northland upgraded SolarEdge (SEDG) to Market Perform from Underperform with a price target of $12.50, down from $15. Shares have declined significantly since the firm cut the stock to Underperform late in February, notes the firm, which estimates that SolarEdge will exit calendar year 2025 with about $350M in net cash and doesn’t expect the company to file for bankruptcy.
  • Citi upgraded Hasbro (HAS) to Buy from Neutral with a $72 price target. The firm says Hasbro has been, by far, the biggest positive surprise of the post-Liberation Day environment to date.

Top 5 Downgrades:

  • RBC Capital downgraded Global Payments (GPN) to Sector Perform from Outperform with a price target of $86, down from $139, following a more detailed review of the Worldpay acquisition and sale of its Issuer business.
  • HSBC downgraded Align Technology (ALGN) to Hold from Buy with a price target of $170, down from $290. The firm adjusted ratings in medical technology and life sciences are quantifying the risk/reward using stagflation, weak macro environment, and recovery scenario analyses.
  • Roth Capital downgraded Canadian Solar (CSIQ) to Neutral from Buy with a price target of $9, down from $15. Over the past 18 months, Canadian Solar’s core module business has been challenged given the global oversupply, the firm tells investors in a research note.
  • HSBC downgraded Iqvia (IQV) to Hold from Buy with a price target of $160, down from $260. HSBC’s analysis of historical sector multiples reveals that the multiples compression might have an additional 20%-25% downside in a stagflation scenario
  • Canaccord downgraded ASGN (ASGN) to Hold from Buy with a price target of $55, down from $115. The company’s Assignment revenue has yet to trough despite what has now been a couple of years since macro headwinds began to appear, the firm tells investors in a research note.

Top 5 Initiations:

  • Citi initiated coverage of Super Micro (SMCI) with a Neutral rating and $39 price target. The firm says its positive view is counterbalanced by an increasingly competitive AI Server landscape pressuring margins.
  • Wells Fargo initiated coverage of Sensata (ST) with an Equal Weight rating and $20 price target. The firm cites its cautious view on tariffs and underlying challenges to the company’s end markets for the neutral rating.
  • JPMorgan initiated coverage of Opko Health (OPK) with a Neutral rating and no price target. The firm believes it will take a series of clinical wins to gain broader investor recognition, with shares likely to trade range-bound over the mid-term.
  • Citizens JMP initiated coverage of SoFi Technologies (SOFI) with an Outperform rating and $17 price target, implying 38% upside from current levels. The firm cites the company’s growth trajectory, improving profitability profile, and undervaluation relative to its earnings potential over time for the Outperform rating.
  • Needham initiated coverage of Rocket Lab (RKLB) with a Buy rating and $28 price target. The firm says Rocket Lab is a “disruptive company in the fast-evolving space sector.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue